Preliminary results of small arterial substitutes performed with a new cylindrical biomaterial composed of bacterial cellulose

Authors:
  • JWJ. Wippermann
    J. Wippermann
  • DSD. Schumann
    D. Schumann
  • DKD. Klemm
    D. Klemm
  • JAJ. M. Albes
    J. M. Albes
  • TWT. Wittwer
    T. Wittwer
  • JSJ. Strauch
    J. Strauch
  • TWT. Wahlers
    T. Wahlers

Abstract
Objective: Tissue engineered blood vessels (TEBV) represent an innovative approach to overcome reconstructive problems associated with extended vascular diseases by providing small calibre vasular grafts. The aim of this study was to evaluate a novel biomaterial of bacterially synthesized cellulose (BC) as a potential scaffold for TEBV. Methods: Crystalline cellulose was produced by a bacterium (Acetobacter xylinum) using glucose as carbon source. Tubes of BC were created with a length of 10mm an inner diameter of 3.0–3.7mm and a wall-thickness of 0.6–1.0mm. These grafts were used to replace the carotid arteries of 8 pigs. After a follow-up period of 3 months grafts were removed and analyzed both macro- and microscopically. Results: After 3 months, seven grafts (87.5%) were patent whereas one graft was occluded. Scanning electron microscopy revealed complete recellularization by recipient endothelial cells. Light microscopy showed a three-layered wall structure of the BC-segments with cellulose still being present in the media. Conclusion: These data demonstrate the potential of BC engineered grafts for small calibre vessel substitution. As the innovative BC engineering technique can provide stable small calibre vascular conduits of any desired size and length it offers a highly attractive approach for future TEBV programs in cardiovascular surgery.